David A. Siegel Galapagos Nv Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Galapagos Nv stock. As of the latest transaction made, Two Sigma Advisers, LP holds 8,700 shares of GLPG stock, worth $272,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,700
Previous 7,500
16.0%
Holding current value
$272,223
Previous $209,000
44.02%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GLPG
# of Institutions
100Shares Held
15.3MCall Options Held
64.6KPut Options Held
39.6K-
Tang Capital Management LLC San Diego, CA4.15MShares$130 Million6.54% of portfolio
-
Madison Avenue Partners, LP New York, NY2.2MShares$68.7 Million6.96% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.67MShares$52.2 Million4.34% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.42MShares$44.3 Million0.01% of portfolio
-
Prosight Management, LP Dallas, TX1.15MShares$36 Million10.53% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $2.06B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...